Raymond Perez
About Raymond Perez
Raymond Perez is the Senior Director of Early Clinical Development in Oncology at Bristol Myers Squibb, based in Lawrenceville, New Jersey.
Current Role at Bristol Myers Squibb
Raymond Perez serves as the Senior Director of Early Clinical Development in Oncology at Bristol Myers Squibb in Lawrenceville, New Jersey. In this role, he oversees the early phases of clinical development for oncology therapies, ensuring the successful initiation and progress of clinical trials. His work includes leading teams responsible for preparing Investigational New Drug (IND) applications and managing site selection and activation processes.
Previous Positions at Bristol Myers Squibb
Before assuming his current role, Raymond Perez served in various capacities at Bristol Myers Squibb. He was the Program Leader for Early Clinical Development in Oncology from 2018 to 2020 and the Senior Early Clinical Lead from 2017 to 2018. During his tenure in these positions, Perez contributed to delivering several First-In-Human (FIH) programs and played a vital role in the technical diligence and acquisition of novel clinical-stage assets.
Academic Background and Positions
Raymond Perez's academic career includes serving as a Professor at the University of Kansas Medical Center from 2011 to 2017 and as an Associate Professor at Dartmouth Medical School from 1998 to 2011. Earlier, he was an Assistant Professor at Roswell Park Cancer Institute from 1992 to 1998. His education began with a Bachelor of Science in Integrated Life Sciences from Kent State University, followed by a Doctor of Medicine (M.D.) from Northeastern Ohio Universities College of Medicine. He completed his Internal Medicine Residency at Michael Reese Hospital and Medical Center/University of Chicago Affiliate and a Medical Oncology Research Fellowship at Fox Chase Cancer Center.
Key Projects and Accomplishments
During his career at Bristol Myers Squibb, Raymond Perez led teams that delivered IND applications and managed First Patient First Visit (FPFV) milestones for multiple programs. He served as the Clinical Subject Matter Expert for the technical diligence of a novel clinical-stage asset, leading to its acquisition and integration. Post-acquisition, he managed the intake of critical data across various domains and authored multiple Clinical Study Reports (CSRs). Additionally, Perez maintained key relationships with investigators and assisted in developing clinical protocols and development plans for acquired assets.
Publications and Contributions to Oncology
Raymond Perez has contributed to the oncology field through multiple publications and professional activities. He co-led a steering committee that delivered a peer-reviewed publication and contributed to five additional peer-reviewed publications in 2021. He also represented Bristol Myers Squibb on ASCO ad-hoc workgroups focused on Broadening Clinical Trials Eligibility. In April 2021, he participated in a webinar related to his work at Bristol Myers Squibb, sharing insights and developments in oncology clinical trials.